Retrospective Analysis of U.S. Claims Data Shows AUVI-Q® (epinephrine injection, USP) Prescription Associated with Lower Rates of Anaphylaxis-Related Inpatient Hospitalizations Compared to Other ...
BRIDGEWATER, N.J.-- Sanofi is recalling hundreds of thousands of epinephrine injectors used to treat severe allergic reactions because they may not deliver the correct amount of the life-saving drug.
Richmond, Virginia, July 24, 2025 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-delivery device technology and auto-injector innovation, today announced that AUVI-Q® (epinephrine injection, USP) ...
* U.S. FDA approves kaléo's AUVI-Q® (Epinephrine injection, USP) 0.1 mg auto-injector for life-threatening allergic reactions in infants and small children Sign up here. * kaléo - AUVI-Q 0.1 mg ...
As part of the back-to-school rush, GoodRx, a platform for medication savings, reports the demand for epinephrine (EpiPen, EpiPen Jr, Adrenaclick, Auvi-Q) auto-injectors tends to spike in the summer ...
The MarketWatch News Department was not involved in the creation of this content. Retrospective Analysis of U.S. Claims Data Shows AUVI-Q(R) (epinephrine injection, USP) Prescription Associated with ...
Richmond, Virginia, May 15, 2025 (GLOBE NEWSWIRE) -- New findings from a retrospective analysis of U.S. commercial claims data indicate that patients prescribed AUVI-Q ® (epinephrine injection, USP) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback